Exact Mass: 244.1787

Exact Mass Matches: 244.1787

Found 57 metabolites which its exact mass value is equals to given mass value 244.1787, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Leucyl-leucine

(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanoic acid

C12H24N2O3 (244.1787)

Leucylleucine is a dipeptide composed of two leucine residues. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. Leu-Leu-OH, a Leu derivative, is a dipeptide.

6-(6-aminohexanamido)hexanoic acid

N-(6-aminohexanoyl)-6-aminohexanoic acid

C12H24N2O3 (244.1787)

Isoleucyl-Isoleucine

2-[(2-Amino-1-hydroxy-3-methylpentylidene)amino]-3-methylpentanoate

C12H24N2O3 (244.1787)

Isoleucyl-Isoleucine is a dipeptied compoosed of two isoleucine residues. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Leucyl-Isoleucine

2-[(2-Amino-1-hydroxy-4-methylpentylidene)amino]-3-methylpentanoate

C12H24N2O3 (244.1787)

Leucyl-Isoleucine is a dipeptide composed of leucine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Isoleucyl-Leucine

2-[(2-Amino-1-hydroxy-3-methylpentylidene)amino]-4-methylpentanoate

C12H24N2O3 (244.1787)

Isoleucyl-Leucine is a dipeptide composed of isoleucine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.